# QuantHealth Funding: How Much It Raised, Its Valuation & Investors

> QuantHealth raised $45 million in a Series B round in August 2026, led by Qumra Capital with participation from Pitango and Sanofi Ventures. Here's the full breakdown of the round and what the AI clinical-trial startup will do with the money.

_[Wortins Blog](https://www.wortins.com/blog) · Published Thursday, August 13, 2026_

**QuantHealth raised $45 million in a Series B round**, announced August 6, 2026 and led by **Qumra Capital**, with **Pitango and Sanofi Ventures** participating. The round backs an AI platform that simulates clinical trials before they happen — a bet on cutting the enormous cost of late-stage drug failures.

Here's the full breakdown of the raise, who backed it, and why simulated clinical trials matter to pharma.

## What is QuantHealth?

QuantHealth builds an **AI platform that simulates clinical trials** to predict outcomes and improve drug development success rates before a trial ever begins. Rather than waiting for a real-world trial to reveal whether a drug will succeed or fail, the platform models how a trial is likely to play out — giving pharmaceutical companies a way to catch problems earlier and cheaper. The company's customers include **12 of the world's top 20 pharmaceutical companies**, a strong signal of enterprise validation for a healthcare AI startup at the Series B stage.

## The raise: $45M Series B

The headline numbers:

- **Amount:** $45 million
- **Round:** Series B
- **Announced:** August 6, 2026
- **Lead investor:** Qumra Capital

QuantHealth hasn't disclosed a post-money valuation or details of its prior funding rounds, so the trajectory of its valuation over time isn't public.

## Who invested in QuantHealth?

The Series B was led by **Qumra Capital**. Additional participants included:

- **Pitango**
- **Sanofi Ventures**

The presence of Sanofi Ventures — the corporate venture arm of a major global pharmaceutical company — alongside financial investors like Qumra Capital and Pitango points to strategic, not just financial, interest in QuantHealth's technology from within the pharma industry itself.

## What QuantHealth will do with the money

QuantHealth said the funding will go toward **scaling adoption and R&D**. The company points to **90% predictive accuracy across more than 600 simulated trials** as evidence its models are ready for broader use — a track record that likely underpins its push to expand within its existing base of top-20 pharma customers and beyond.

## Why it matters

1. **AI is attacking one of pharma's most expensive problems.** Late-stage clinical trial failures can cost hundreds of millions of dollars and delay therapies for years, so a platform with a credible predictive track record has an unusually clear return-on-investment case to make to enterprise buyers.
2. **Deep-pocketed pharma incumbents are already customers, not just prospective ones.** Having 12 of the top 20 pharmaceutical companies as customers at the Series B stage is a level of enterprise traction that's uncommon this early, and it puts QuantHealth in a strong position relative to the broader wave of AI healthcare funding tracked across [the biggest AI funding rounds of 2026](/blog/biggest-ai-funding-rounds-2026).
3. **Strategic corporate investment signals durable demand.** Sanofi Ventures' participation suggests at least one major pharma company sees enough value in QuantHealth's simulations to back it directly, rather than simply licensing the technology as an arms-length customer.

Source: [FinSMEs — QuantHealth raises $45M in Series B funding](https://www.finsmes.com/2026/08/quanthealth-raises-45m-in-series-b-funding.html)

---

*Following AI funding? Wortins tracks the biggest raises, valuations, and acquisitions daily in the [AI Funding Tracker](/funding).*

## Frequently asked questions

### How much did QuantHealth raise?

QuantHealth raised $45 million in a Series B round announced on August 6, 2026.

### What is QuantHealth's valuation?

QuantHealth's valuation following the Series B has not been disclosed.

### Who invested in QuantHealth?

The round was led by Qumra Capital, with participation from Pitango and Sanofi Ventures.

### What does QuantHealth do?

QuantHealth builds an AI platform that simulates clinical trials to predict outcomes and improve drug development success rates. Its customers include 12 of the world's top 20 pharmaceutical companies.

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._